GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
1.4k
c/glp1science·posted 2 years ago by u/elodie_grimaldi

does receptor actually matter or is it forum lore at this point

Speculation Cold Box ×2 Long Haul ×3

Slightly embarrassed to be asking this, but: does receptor actually matter or is it forum lore at this point.

Spent an evening on the receptor distribution literature and the side-effect map suddenly stopped looking random.

Tried to build a mental model from mechanism alone and produced a confident prediction that the trial data flatly contradicted.

The half-life explanation was the thing that made weekly dosing intuitive for me rather than arbitrary.

Would rather be corrected in public than confident in private.

1,751 up / 352 down83% upvoted52 commentsid 1yjksc6 May 2024

52 comments

24 in this archive, depth 4

best — the order this archive was captured in

u/ilias_kaufmann89 points·2 years ago

The incretin effect is the observation that oral glucose provokes a larger insulin response than intravenous glucose at matched glycaemia, and the difference is mediated by gut hormones. That is the foundation the whole class sits on.

replysharereportpermalink
u/flair_enthusiast-36 points·2 years ago

Why mechanism talk keeps misleading people, including me.

A mechanism tells you a direction. It does not tell you a magnitude, a timescale, or whether the pathway is operative at the exposures involved. "Receptor X is expressed in tissue Y" is a fact; "therefore effect Z in a person" is a hypothesis with several missing steps.

The corrective is boring and it works: ask whether the evidence is preclinical or human, ask what exposure was used, and read the limitations section before the abstract. Most of the confidently wrong posts on this board — several of them mine — skipped all three.

replysharereportpermalink
u/yannick_barros1 point·2 years ago

gastric emptying slows, it does not stop

replysharereportpermalink
u/enzo_petrescu1 point·2 years ago

GIP is the arm people argue about because the biology is genuinely unsettled

replysharereportpermalink
[deleted]1 point·2 years ago

[deleted]

replysharereportpermalink
u/elodie_grimaldiOP0 points·2 years ago

Is that from a human study or a preclinical model?

replysharereportpermalink
u/camila_lindqvist1 point·2 years ago

Is there any human data on that mechanism yet?

replysharereportpermalink
u/whois_wanda51 points·2 years ago

Does the effect persist with continued dosing or does tolerance develop?

replysharereportpermalink
u/lina_ndiaye14 points·2 years ago

GIP receptor biology is genuinely unsettled — there is a live argument about agonism versus antagonism at the receptor — and the clinical results are robust regardless, which is an uncomfortable and interesting position.

replysharereportpermalink
u/emil_agyeman4 points·2 years ago

preclinical is not clinical and rodents are not small people

replysharereportpermalink
u/nadia_bakker1 point·2 years ago

a mechanism you can state is not a mechanism you have demonstrated

replysharereportpermalink
u/second_week_sceptic11 points·2 years ago

incretin effect first, then everything else in this board makes sense

replysharereportpermalink
u/rina_bergstrom5 points·2 years ago·edited

incretin effect first, then everything else in this board makes sense

Adding the caveat the paper itself makes in its limitations section, which is stronger than anything in this thread.

replysharereportpermalink
u/plain_titration8 points·2 years ago

Asked a question here that I thought was stupid and got three papers back. Best thread I have been in on this site.

replysharereportpermalink
u/incretin_ivypharmacology0 points·2 years ago

Was completely wrong about the gastric emptying story in a thread here two years ago. Someone corrected me with a citation and I have not made that mistake since.

replysharereportpermalink
u/slow_logbook23 points·2 years ago

Which receptor arm are you attributing that to?

replysharereportpermalink
u/sanne_delgado16 points·2 years ago

What was the exposure in that experiment relative to therapeutic?

replysharereportpermalink
u/bastian_ekstrom13 points·2 years ago

Do you have the paper, or a summary of it?

replysharereportpermalink
u/devils_advocate_d10 points·2 years ago

The GIP question, which is the most interesting unsettled thing in this field.

Dual agonism at GIP and GLP-1 receptors produces clinical results that are robust and well replicated. What is not settled is the mechanism by which the GIP arm contributes — there is a genuine scientific argument about agonism versus antagonism at that receptor, with reasonable people and real data on both sides.

It is worth sitting with that. The clinical effect is not in doubt; the explanation is. That is an ordinary state of affairs in pharmacology and it is a good corrective to the confident mechanistic stories that circulate here.

replysharereportpermalink
u/nhs_waitlist_nUK15 points·2 years ago

dose response is not linear and nobody should assume it is

replysharereportpermalink
u/marisol_kravchenko7 points·2 years ago

Went looking for human data on a mechanism everybody here asserts. Found preclinical work and one small study. That was clarifying.

replysharereportpermalink
u/laila_almeida8 points·2 years ago

Read the primary paper after arguing about the summary for a fortnight. The discussion section said almost the opposite of what the thread had concluded.

replysharereportpermalink
u/nora_lundgren3 points·2 years ago

mechanism explains a direction, not a magnitude

replysharereportpermalink
u/nurse_ish_202510 points·2 years ago

read the discussion section, that is where the honesty lives

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/glp1science

The mechanism layer: incretin physiology, receptor distribution, gastric emptying, central appetite signalling, glucagon-receptor contribution, amylin co-agonism, and the pharmacokinetics that make weekly dosing possible. Papers get cited by journal and year or they get a [needs source] reply.

50kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/glp1science rules
  1. Cite the paper: journal, year, first author. Links optional, citation mandatory.
  2. Mechanistic speculation is welcome if flaired as speculation.
  3. No extrapolating rodent data to human dosing without saying that is what you are doing.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.